Multiple Sclerosis
Updated: 02/14/2006
References
Agnello E, Palmo A. The efficacy of dietetic intervention in multiple sclerosis. Minerva Gastroenterol Dietol . 2004 Dec;50(4):317-23.
Agranoff BWA, Goldberg D. Diet and the geographical distribution of multiple sclerosis. Lancet. 1974 Nov 2;2(7888):1061-6.
Alotaibi S, Kennedy J, et al. Epstein-Barr virus in pediatric multiple sclerosis. JAMA. 2004 Apr 21;291(15):1875-9.
Arfsten D, Johnson E, et al. Impact of 30-day oral dosing with N-acetyl-L-cysteine on Sprague-Dawley rat physiology. Int J Toxicol. 2004 Jul-Aug;23(4):239-47.
Bannenberg GL, Chiang N, Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol. 2005 Apr 1;174(7):4345-55.
Bansil S, Lee HJ, et al. Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta Neurol Scand. 1999 Feb;99(2):91-4.
Bates D. Dietary lipids and multiple sclerosis. Ups J Med Sci Suppl . 1990;48:173-87.
Bates MN, Fawcett J, et al. Health effects of dental amalgam exposure: a retrospective cohort study. Int J Epidemiol. 2004 Aug;33(4):894-902. Epub 2004 May 20.
Biernacki K, Prat A, et al. Regulation of cellular and molecular trafficking across human brain endothelial cells by Th1- and Th2-polarized lymphocytes. J Neuropathol Exp Neuro l. 2004 Mar;63(3):223-32.
Bonakdar RA, Guarneri E, et al. Coenzyme Q10. Am Fam Physician . 2005 Sep 15;72(6):1065-70.
Butcher J. The distribution of multiple sclerosis in relation to the dairy industry and milk consumption. N Z Med J. 1976 Jun 23;83(566):427-30.
Calabrese VP, Isaacs ER, et al. Dehydroepiandrosterone in multiple sclerosis: positive effects on the fatigue syndrome in a non-randomized study. In: Kalimi M, Regelson W, eds. The Biological Role of Dehydroepiandrosterone (DHEA). New York, NY : Walter de Gruyter; 1990:95-100.
Cantorna MT, Hayes CE, et al. 1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A . 1996 Jul 23;93(15):7861-4.
Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med. 2000 Mar;223(3):230-3.
Chaudhuri A. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med Hypotheses . 2005;64(3):608-18.
Chofflon M. Mechanisms of action for treatments in multiple sclerosis: does a heterogeneous disease demand a multi-targeted therapeutic approach? BioDrugs . 2005;19(5):299-308.
Cournu-Rebeix I, Genin E, et al. Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosis. Genes Immun. 2003 Oct;4(7):518-23.
de Bustos F, Jimenez-Jimenez FJ, et al. Serum levels of coenzyme Q10 in patients with multiple sclerosis. Acta Neurol Scand . 2000 Mar;101(3):209-11.
Dedrick RL, Bodary S, et al. Adhesion molecules as therapeutic targets for autoimmune diseases and transplant rejection. Expert Opin Biol Ther. 2003 Feb;3(1):85-95.
Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation. J Neuroimmunol. 2000 Nov 1;111(1-2):77-85.
Du C, Khalil MW, et al. Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice. J Immunol . 2001 Dec 15;167(12):7094-101.
Dworkin RH, Bates D, et al. Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials. Neurology. 1984 Nov;34(11):1441-5.
El-Etr M, Vukusic S, et al. Steroid hormones in multiple sclerosis. J Neurol Sci . 2005 Jun 15;233(1-2):49-54. Review.
Farrell R, Heaney D, et al. Emerging therapies in multiple sclerosis. Expert Opin Emerg Drugs. 2005 Nov;10(4):797-816.
Feng J, Misu T, et al. Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1/Th2 balance and NKT cell subset in multiple sclerosis. Mult Scler. 2004 Oct;10(5):494-8.
Ferrucci L, Cherubini A, et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab . 2005 Oct 18; [Epub ahead of print]
Garcion E, Sindji L, et al. Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system. Acta Neuropathol (Berl). 2003 May;105(5):438-48. Epub 2003 Jan 31.
Gilgun-Sherki Y, Barhum Y, et al. Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant. J Mol Neurosci . 2005;27(1):125-35.
Guggenmos J, Schubart AS, et al. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. J Immunol . 2004 Jan 1;172(1):661-8.
Haahr S, Munch M. The association between multiple sclerosis and infection with Epstein-Barr virus and retrovirus. J Neurovirol. 2000 May;6(suppl 2):S76-9. Review.
Hanley DA, Davison KS. Vitamin D insufficiency in North America. J Nutr . 2005 Feb;135(2):332-7.
Harbige LS, Fisher BA. Dietary fatty acid modulation of mucosally induced tolerogenic immune responses. Proc Nutr Soc . 2001 Nov;60(4):449-56.
Harbige LS, Layward L, et al. The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production. Clin Exp Immunol. 2000 Dec;122(3):445-52.
Hartung HP, Bar-Or A, et al. What do we know about the mechanism of action of disease-modifying treatments in MS? J Neurol . 2004 Sep;251(suppl 5):v12-v29.
Henke AF, Cohle SD, et al. Fatal hyperthermia secondary to sunbathing in a patient with multiple sclerosis. Am J Forensic Med Pathol . 2000 Sep;21(3):204-6.
Hoffman GE, Le WW, et al. Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats. Exp Neurol . 2001 Oct;171(2):272-84.
Holick MF. The vitamin D epidemic and its health consequences. J Nutr . 2005 Nov;135(11):2739S-48S.
Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005 Feb;135(2):317-22.
Homa ST, Conroy DM, et al. Fatty acid patterns of red blood cell phospholipids in patients with multiple sclerosis. Lancet. 1981 Aug 29;2(8244):474.
Horrobin DF. Essential fatty acid metabolism and its modification in atopic eczema. Am J Clin Nutr . 2000 Jan;71(suppl 1):367S-72S.
Horrobin DF. Essential fatty acids in the management of impaired nerve function in diabetes. Diabetes. 1997 Sep;46(suppl 2):S90-3.
Hughes MD. Multiple sclerosis and pregnancy. Neurol Clin. 2004 Nov;22(4):757-69. Review.
Jamal GA. The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy. Diabet Med. 1994 Mar;11(2):145-9.
Kidd PM. Multiple sclerosis, an autoimmune inflammatory disease: prospects for its integrative management. Altern Med Rev . 2001 Dec;6(6):540-66.
Kim S, Liva SM, et al. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology. 1999 Apr 12;52(6):1230-8.
Kohlmeier RE, DiMaio VJ, et al. Fatal hyperthermia in hot baths in individuals with multiple sclerosis. Am J Forensic Med Pathol . 2000 Sep;21(3):201-3.
Kumpfel T, Then Bergh F, et al. Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis. Neuroendocrinology . 1999 Dec;70(6):431-8.
Landtblom AM, Flodin U, et al. Organic solvents and multiple sclerosis: a synthesis of the current evidence. Epidemiology . 1996 Jul;7(4):429-33.
Lauer K. Diet and multiple sclerosis. Neurology 1997;49:S55-S61.
Lauer K, Firnhaber W. An evaluation of laboratory investigations in patients with multiple sclerosis. J Chronic Dis . 1986;39(10):767-74.
Lieb K, Engels S, et al. Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells. Neurochem Int . 2003 Jan;42(2):131-7.
Mai J, Sorensen PS, et al. High-dose antioxidant supplementation to MS patients: effects on glutathione peroxidase, clinical safety, and absorption of selenium. Biol Trace Elem Res. 1990 Feb;24(2):109-17.
Malosse D, Perron H. Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study. Neuroepidemiology. 1992;11(4-6):304-12.
Marracci GH, Jones RE, et al. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J Neuroimmunol . 2002 Oct;131(1-2):104-14.
Marracci GH, McKeon GP, et al. Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis. J Neurosci Res . 2004 Nov 1;78(3):362-70.
Mazzella GL, Sinforiani E, et al. Blood cells glutathione peroxidase activity and selenium in multiple sclerosis. Eur Neurol . 1983;22(6):442-6.
Merlino LA, Curtis J, et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum. 2004 Jan;50(1):72-7.
Miller A, Korem M, et al. Vitamin B12, demyelination, remyelination and repair in multiple sclerosis . J Neurol Sci. 2005 Jun 15;233(1-2):93-7.
Miller DH, Khan OA, et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2003 Jan 2;348(1):15-23.
Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an authentic strength-preserving hormone. Mol Aspects Med. 2005 Jun;26(3):203-19.
Morini M, Roccatagliata L, et al. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. J Neuroimmunol . 2004 Mar;148(1-2):146-53.
Munch M, Hvas J, et al. The implications of Epstein-Barr virus in multiple sclerosis: a review. Acta Neurol Scand Suppl . 1997;169:59-64.
Munger KL, Zhang SM, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology . 2004 Jan 13;62(1):60-5.
Murdoch D, Lyseng-Williamson KA. Spotlight on subcutaneous recombinant interferon-beta-1a (Rebif) in relapsing-remitting multiple sclerosis. BioDrugs . 2005;19(5):323-5.
Mutter J, Naumann J, et al. Amalgam risk assessment with coverage of references up to 2005. Gesundheitswesen . 2005 Mar;67(3):204-16.
Noonan CW, Kathman SJ, et al. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology. 2002 Jan 8;58(1):136-8.
Nordvik I, Myhr KM, et al. Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand. 2000 Sep;102(3):143-9.
Noseworthy JH. Multiple sclerosis clinical trials: old and new challenges. Semin Neurol. 1998;18(3):377-88. Review.
Offner H, Zamora A, et al. A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE. J Neuroimmunol . 2002 Sep;130(1-2):128-39.
Patten SB, Metz LM. Depression in multiple sclerosis. Psychother Psychosom . 1997;66(6):286-92. Review.
Polman CH, Uitdehaag BM. New and emerging treatment options for multiple sclerosis. Lancet Neurol . 2003 Sep;2(9):563-6.
Ponsonby AL, Lucas RM, et al. A potential role for UVR and vitamin D in the induction of multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem Photobiol . 2005a Feb 1; [Epub ahead of print]
Ponsonby AL, Lucas RM, et al. UVR, vitamin D and three autoimmune diseases: multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem Photobiol. 2005b Nov-Dec;81(6):1267-75.
Ponsonby AL, McMichael A, et al. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology . 2002 Dec 27;181-182:71-8.
Pozzilli C, Falaschi P, et al. MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns. Neurology . 1999 Aug 11;53(3):622-4.
Prieto JM, Dapena D, et al. Pentoxifylline: is it useful in multiple sclerosis? Rev Neurol. 2001 Mar 16-31;32(6):529-31.
Prochazkova J, Sterzl I, et al. The beneficial effect of amalgam replacement on health in patients with autoimmunity. Neuro Endocrinol Lett. 2004 Jun;25(3):211-8.
Ramsaransing GS, Heersema DJ, et al. Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosis. Eur J Neurol . 2005 Jul;12(7):514-8.
Reynolds EH. Multiple sclerosis and vitamin B12 metabolism. J Neuroimmunol . 1992 Oct;40(2-3):225-30.
Riise T, Moen BE, et al. Organic solvents and the risk of multiple sclerosis. Epidemiology. 2002 Nov;13(6):718-20.
Schwarz S, Leweling H. Multiple sclerosis and nutrition. Mult Scler . 2005 Feb;11(1):24-32.
Serhan CN. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem Cell Biol. 2004 Oct;122(4):305-21. Epub 2004 Aug 21.
Serhan CN. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr Opin Clin Nutr Metab Care . 2005a Mar;8(2):115-21.
Serhan CN. Novel omega-3–derived local mediators in anti-inflammation and resolution. Pharmacol Ther . 2005b Jan;105(1):7-21.
Shapiro H. Could n-3 polyunsaturated fatty acids reduce pathological pain by direct actions on the nervous system? Prostaglandins Leukot Essent Fatty Acids. 2003 Mar;68(3):219-24.
Siblerud RL, Kienholz E. Evidence that mercury from silver dental fillings may be an etiological factor in multiple sclerosis. Sci Total Environ. 1994 Mar 15;142(3):191-205.
Siemieniuk E, Skrzydlewska E. Coenzyme Q10: its biosynthesis and biological significance in animal organisms and in humans. Postepy Hig Med Dosw (Online). 2005 Apr 18;59:150-9.
Singh I, Pahan K, Cytokine-mediated induction of ceramide production is redox-sensitive: implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases . J Biol Chem. 1998 Aug 7;273(32):20354-62.
Smith KJ, McDonald WI. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci . 1999 Oct 29;354(1390):1649-73. Review.
Sorensen PS, Fazekas F, et al. Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-analysis. Eur J Neurol . 2002 Nov;9(6):557-63.
Stefferl A, Schubart A, et al. Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. J Immunol. 2000 Sep 1;165(5):2859-65.
Steiner I, Nisipianu P, et al. Infection and the etiology and pathogenesis of multiple sclerosis. Curr Neurol Neurosci Rep . 2001 May;1(3):271-6. Review.
Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet. 1990 Jul 7;336(8706):37-9.
Swank RL. Multiple sclerosis: fat-oil relationship. Nutrition . 1991 Sep-Oct;7(5):368-76.
Syburra C, Passi S. Oxidative stress in patients with multiple sclerosis. Ukr Biokhim Zh . 1999 May-Jun;71(3):112-5.
Trenova AG, Manova MM, et al. Female sex hormones and multiple sclerosis. Folia Med ( Plovdiv ). 2004;46(4):11-5. Review.
van Meeteren ME, Teunissen CE, et al. Antioxidants and polyunsaturated fatty acids in multiple sclerosis. Eur J Clin Nutr . 2005 Dec;59(12):1347-61.
Vollmer TL, Phillips JT, et al. An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis. Mult Scler. 2004 Oct;10(5):511-20.
Wade DT, Young CA, et al. A randomised placebo-controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):246-9.
Weinshenker BG. The natural history of multiple sclerosis. Neurol Clin. 1995 Feb;13(1):119-46.
Weinstock-Guttman B, Baier M, et al. Low-fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids . 2005 Nov;73(5):397-404.
Willer CJ, Dyment DA, et al. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A . 2003 Oct 28;100(22):12877-82. Epub 2003 Oct 20.
Willer CJ, Ebers GC. Susceptibility to multiple sclerosis: interplay between genes and environment. Curr Opin Neurol. 2000 Jun;13(3):241-7.
Wingerchuk DM, Lesaux J, et al. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry . 2005 Sep;76(9):1294-6.
Wright JV. Multiple sclerosis. Nutrition & Healing 1997;4:1-12.
Yadav V, Marracci G, et al. Lipoic acid in multiple sclerosis: a pilot study. Mult Scler. 2005 Apr;11(2):159-65.
Zhang SM, Willett WC, et al. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol. 2000 Dec 1;152(11):1056-64.